SALOR-INT L397873-1EA

SALOR-INT L397873-1EA Suppliers list
Company Name: Merck KGaA  
Tel: (+86) 21 2033 8288
Email: sigmaname@qq.com
Products Intro: Product Name:2-(2-(9-ANTHRYLMETHYLENE)HYDRAZINO)-N-(4-METHYLPHENYL)-2-OXOACETAMIDE
CAS:769148-19-8
Company Name: Riedel-de Haen AG  
Tel: 800 558-9160
Email:
Products Intro:
SALOR-INT L397873-1EA Basic information
Product Name:SALOR-INT L397873-1EA
Synonyms:SALOR-INT L397873-1EA;2-(2-(9-ANTHRYLMETHYLENE)HYDRAZINO)-N-(4-METHYLPHENYL)-2-OXOACETAMIDE
CAS:769148-19-8
MF:C24H19N3O2
MW:381.43
EINECS:
Product Categories:
Mol File:769148-19-8.mol
SALOR-INT L397873-1EA Structure
SALOR-INT L397873-1EA Chemical Properties
Safety Information
MSDS Information
SALOR-INT L397873-1EA Usage And Synthesis
SALOR-INT L397873-1EA Preparation Products And Raw materials
Tag:SALOR-INT L397873-1EA(769148-19-8) Related Product Information
SALOR-INT L399302-1EA SALOR-INT L463302-1EA SALOR-INT L491152-1EA SALOR-INT L397873-1EA

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.
This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept